denenicokin
Term · Oncology and biomedicine · MLC-T-ONC-012973
A recombinant peptide similar to or identical to endogenous human cytokine interleukin-21 (IL-21) with potential antineoplastic activity. Denenicokin binds to and activates IL-21 receptors, expressed on T-cells, B-cells, dendritic cells (DC), and natural killer (NK) cells, modulating the proliferation and/or differentiation of T and B cells, promoting T cell survival, and increasing the cytolytic activity of cytotoxic T lymphocytes (CTLs) and NK cells.
| Identifier | MLC-T-ONC-012973 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | rhIL-21 |
| Synonyms | recombinant human interleukin-21 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012973",
"term": "denenicokin",
"field": "Oncology and biomedicine",
"definition": "A recombinant peptide similar to or identical to endogenous human cytokine interleukin-21 (IL-21) with potential antineoplastic activity. Denenicokin binds to and activates IL-21 receptors, expressed on T-cells, B-cells, dendritic cells (DC), and natural killer (NK) cells, modulating the proliferation and/or differentiation of T and B cells, promoting T cell survival, and increasing the cytolytic activity of cytotoxic T lymphocytes (CTLs) and NK cells.",
"abbreviation": "rhIL-21",
"synonyms": [
"recombinant human interleukin-21"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/denenicokin/"
}
Record 5,817 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.